Company Profile - Investors
Nuventix raised its initial venture capital funded round of $6.5M in September of 2005 from Centerpoint Ventures, InterWest Partners and RHO Ventures.

CenterPoint Ventures

CenterPoint Ventures is one of Texas' largest early-stage venture capital firms. CenterPoint's target investment areas are communications infrastructure, business software technologies, semiconductor products, and new industrial technologies. CenterPoint's investment strategy combines market timing and focus, technology expertise, strategic relationships, entrepreneurial and corporate experience, and a commitment to succeed. Building on a strong technical and operational foundation, CenterPoint invests in the areas where they contribute the highest degree of expertise and value and aim to define and dominate strategic business-to-business areas.

More information on CenterPoint is available at www.cpventures.com.


InterWest Partners

InterWest Partners is a leading diversified venture capital firm currently investing InterWest IX, a $600 million fund. Investing since 1979, we build long-term relationships with entrepreneurs and portfolio companies. Our experienced partners, who bring together deep domain knowledge in information technology and life sciences, have established a proven track record of identifying, validating and backing emerging trends and technologies. With more than $2B capital under management, we take a long-term, collaborative approach to venture funding, providing early stage and ongoing capital, management coaching and access to a broad network of resources.

More information can be found at www.interwest.com.


RHO Ventures

RHO Ventures is a venture capital firm with extensive investments in the healthcare, information technology and communication sectors. Since it was founded in 1981, the firm has invested in over 150 venture stage companies and helped build market leaders across many high growth industries. The firm's activities span all classes of private equity investments, including venture capital in early stage technology and healthcare companies, direct private equity investments in more mature companies, and fund investments in all classes of venture capital and private equity funds. Total capital under management currently exceeds $2.2 billion.

More information can be found at www.rho.com.

back to top